SnapShot: COVID-19

Blake Oberfeld1, Aditya Achanta1, Kendall Carpenter1

  • 1Harvard Medical School, Boston, MA 02115, USA.

Cell
|May 16, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, can lead to severe illness. Research is ongoing for treatments like antivirals and vaccines to combat this respiratory illness.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • COVID-19 is a novel respiratory illness caused by the SARS-CoV-2 virus.
  • Viral entry into host cells is facilitated by the interaction between the SARS-CoV-2 spike protein and the human ACE2 enzyme.
  • While most COVID-19 cases present with mild symptoms, severe disease can manifest as cytokine storm and multi-organ failure.

Purpose of the Study:

  • To provide an overview of COVID-19, its causative agent, and disease mechanisms.
  • To highlight the current status of therapeutic development for COVID-19.
  • To inform about the potential severity and complications associated with SARS-CoV-2 infection.

Main Methods:

  • This is a summary of current knowledge on COVID-19.
  • Information is compiled from existing research and clinical observations.
  • No new experimental data was generated for this overview.

Main Results:

  • SARS-CoV-2 utilizes the ACE2 enzyme for host cell entry, initiating infection.
  • Severe COVID-19 is characterized by a dysregulated immune response (cytokine storm) leading to organ damage.
  • Therapeutic strategies are under active investigation.

Conclusions:

  • Understanding the SARS-CoV-2 lifecycle and pathogenesis is crucial for developing effective treatments.
  • Antivirals, immunomodulators, and vaccines are key areas of therapeutic research.
  • Continued research is essential to manage and mitigate the impact of COVID-19.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
394
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
418